Interleukin-1-alpha targeting antibody - XBiotech
Alternative Names: anti-interleukin-1-alpha (IL-1α), human IgG1 monoclonal antibody; anti-interleukine-1alpha True Human™ Antibody - XBiotech; Hutrukin™Latest Information Update: 21 Apr 2025
At a glance
- Originator XBiotech
- Class Anti-inflammatories; Monoclonal antibodies
- Mechanism of Action Interleukin 1 alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Stroke
- No development reported Inflammation